Geron GERN
NASDAQ GERN
$1.24 +0.04 (+3.33%)
At close: Oct 20, 2026 · 4:00 PM EDT

Geron (GERN) Raw Materials (2024)

Updated

Geron (GERN) reported Raw Materials of $4.9 million for Q4 2024, down 16.5% from the prior quarter.

Analysis

Geron (GERN) Raw Materials (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Geron 827.50 Mn -524.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 4.90 Mn
Sep 30, 2024 5.87 Mn
API Access

Geron Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=GERN&period=max&api_key=YOUR_API_KEY